Olympiad Research’s West Pharmaceutical WST Stock Holding History

Olympiad Research’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,127	Closed	-$256K	–	456
2020 Q2	$256K	Buy	+1,127	New	+$221K	0.18%	159

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Olympiad Research's WST Position: Q3 2020 in Review

Olympiad Research sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 1,127 shares — an estimated $256K sold.

Olympiad Research first reported a position in WST in Q2 2020 and held it in 1 quarter. The position peaked at $256K in Q2 2020. 573 funds tracked by Wall St. Rank hold WST as of Q3 2020.

Olympiad Research reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
Olympiad Research sold 1,127 West Pharmaceutical shares in Q3 2020, an estimated $256K.
Olympiad Research first reported a position in West Pharmaceutical in Q2 2020 and held it in 1 quarter.
Olympiad Research's West Pharmaceutical position peaked at $256K in Q2 2020.
573 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on Olympiad Research's 13F filing for Q3 2020, filed 2 Nov 2020.